FC
VNDA icon

FORA Capital’s Vanda Pharmaceuticals VNDA Stock Holding History

FORA Capital’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,990
Closed -$129K – 865
2021
Q2 		$129K Buy
+5,990
New +$107K 0.02% 534
2020
Q2 		– Sell
-3,058
Closed -$32K – 1338
2020
Q1 		$32K Sell
3,058
-1,012
-25% -$12.5K 0.01% 875
2019
Q4 		$67K Buy
+4,070
New +$61.5K 0.01% 845

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

FORA Capital's VNDA Position: Q3 2021 in Review

FORA Capital sold out of Vanda Pharmaceuticals (VNDA) in Q3 2021, closing a stake of 5,990 shares — an estimated $129K sold.

FORA Capital first reported a position in VNDA in Q4 2019 and held it in 3 quarters. The position peaked at $129K in Q2 2021. 182 funds tracked by Wall St. Rank hold VNDA as of Q3 2021.

  • FORA Capital reported no remaining Vanda Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • FORA Capital sold 5,990 Vanda Pharmaceuticals shares in Q3 2021, an estimated $129K.
  • FORA Capital first reported a position in Vanda Pharmaceuticals in Q4 2019 and held it in 3 quarters.
  • FORA Capital's Vanda Pharmaceuticals position peaked at $129K in Q2 2021.
  • 182 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2021.

Based on FORA Capital's 13F filing for Q3 2021, filed 15 Nov 2021.